Related Experiment Video
Updated: Jun 7, 2026

Insulin Injection and Hemolymph Extraction to Measure Insulin Sensitivity in Adult Drosophila melanogaster
Published on: June 30, 2011
Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use
Sherwyn L Schwartz1, Debra A Ignaut, Jennifer N Bodie
1DGD Research, 5107 Medical Drive, San Antonio, TX 78229, USA.
Insulin pens, like the Humalog KwikPen, are easier to use, more accurate, and preferred by patients over traditional vial and syringe methods for diabetes management. This device offers improved injection experience and dosing precision.
Area of Science:
- Endocrinology
- Diabetes Management
- Medical Device Technology
Background:
- Insulin therapy is crucial for diabetes management.
- Traditional vial and syringe methods present challenges in ease of use and dosing accuracy.
- Insulin pens offer potential advantages for patient self-administration.
Purpose of the Study:
- To evaluate the usability and patient preference of the Humalog KwikPen compared to other insulin delivery devices.
- To assess the dosing accuracy and injection experience of the Humalog KwikPen.
Main Methods:
- Patient preference studies comparing Humalog KwikPen to a comparator pen and vial/syringe.
- Engineering analysis of injection smoothness and dosing error.
- Usability assessments by patients with diabetes.
Main Results:
- Patients highly rated the Humalog KwikPen for ease of use.
- The Humalog KwikPen was preferred over a comparable insulin pen and vial/syringe in comparator studies.
- Engineering data showed smoother injections and reduced dosing error compared to a comparator pen.
Conclusions:
- The Humalog KwikPen is an accurate and easy-to-use insulin pen.
- Patient preference data supports the Humalog KwikPen as a superior option for insulin delivery.
- Evidence indicates the Humalog KwikPen enhances the patient experience in diabetes self-care.
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into rapid-acting...
Oral Hypoglycemic Agents: Glinides
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Hypoglycemia

